Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

NCT06385821

Conditions
Acute Respiratory Infection, Flu, Flu, Human, +14 more
Locations
  • Federal State Budgetary Research Institution "Russian research center of surgery named after academician B.V. Petrovsky" Moscow, Russia
  • State Budgetary Healthcare Institution "Children's City Clinical Hospital No.9 named after G.N. Speransky of Moscow Healthcare Department" Moscow, Russia
  • State Budgetary Health Institution of the Perm Territory "City Children's Clinical Polyclinic No. 5 Perm, Russia
  • Limited Liability Company "Clinic USI 4D" Pyatigorsk, Russia
View all 14 locations
View Trial Details
Completed

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

NCT04576702

Conditions
Human, Infections, Influenza, +6 more
Locations
  • 4022 - Coastal Clinical Research, an AMR company Mobile, Alabama, United States
  • 4002 - Clinical Research Consortium, an AMR company Tempe, Arizona, United States
  • 4006 - Westside Center for Clinical Research Jacksonville, Florida, United States
  • 4013 - Jacksonville Center for Clinical Research Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Completed

Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.

NCT02663102

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Busan, South Korea
  • GSK Investigational Site Daegu, South Korea
  • GSK Investigational Site Daegu, South Korea
  • GSK Investigational Site Daegu, South Korea
View all 21 locations
View Trial Details
Completed

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

NCT05028361

Conditions
Adverse Drug Event, COVID-19, Chemically-Induced Disorders, +20 more
Locations
  • John Hopkins University Baltimore, Maryland, United States
  • Duke University Durham, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

NCT03315104

Conditions
Infections, Influenza A H1N1, Influenza A H3N2, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • HonorHealth Scottsdale, Arizona, United States
  • Baptist Health Center for Clinical Research Little Rock, Arkansas, United States
  • University of California, Irvine Emergency Medicine Orange, California, United States
View all 55 locations
View Trial Details
Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

NCT01006798

Conditions
Animal Diseases, Bird Diseases, Bird Flu, +9 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • The Center for Pharmaceutical Research Kansas City, Missouri, United States
  • University of Rochester Rochester, New York, United States
  • Coastal Carolina Research Center, Inc. Mt. Pleasant, South Carolina, United States
View Trial Details

Related conditions